Green Lifescience Co., Ltd. (KOSDAQ:114450)
South Korea
· Delayed Price · Currency is KRW 1,626.00
-13.00 (-0.79%)
At close: Mar 21, 2025, 3:30 PM KST
Green Lifescience Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 24,861 | 22,369 | 36,505 | 25,338 | 24,561 | Upgrade
|
| Other Revenue | - | 0 | 0 | 0 | - | Upgrade
|
| Revenue | 24,861 | 22,369 | 36,505 | 25,338 | 24,561 | Upgrade
|
| Revenue Growth (YoY) | 11.14% | -38.72% | 44.07% | 3.16% | -34.71% | Upgrade
|
| Cost of Revenue | 21,881 | 24,683 | 37,861 | 27,608 | 24,635 | Upgrade
|
| Gross Profit | 2,980 | -2,313 | -1,356 | -2,270 | -74.77 | Upgrade
|
| Selling, General & Admin | 1,685 | 1,996 | 2,027 | 2,085 | 1,736 | Upgrade
|
| Research & Development | 734.99 | 112.11 | 425.82 | 109.59 | - | Upgrade
|
| Other Operating Expenses | 11.75 | 3.08 | 7.57 | 0.53 | 0.54 | Upgrade
|
| Operating Expenses | 2,603 | 2,330 | 2,602 | 2,378 | 1,834 | Upgrade
|
| Operating Income | 376.91 | -4,643 | -3,958 | -4,648 | -1,909 | Upgrade
|
| Interest Expense | -238.06 | -240.43 | -113.34 | -22.2 | -18.87 | Upgrade
|
| Interest & Investment Income | 453.73 | 697.58 | 626.6 | 674.92 | 554.94 | Upgrade
|
| Currency Exchange Gain (Loss) | 988.53 | -55.15 | -5.29 | -18.17 | -34.79 | Upgrade
|
| Other Non Operating Income (Expenses) | 125.65 | -65.72 | -106.51 | 181.34 | -100.49 | Upgrade
|
| EBT Excluding Unusual Items | 1,707 | -4,307 | -3,557 | -3,832 | -1,508 | Upgrade
|
| Gain (Loss) on Sale of Investments | -144.81 | 43.71 | 694.8 | 416.74 | 636.86 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 1.39 | -2.24 | - | Upgrade
|
| Asset Writedown | - | -12,095 | - | - | - | Upgrade
|
| Pretax Income | 1,562 | -16,358 | -2,860 | -3,418 | -871.4 | Upgrade
|
| Income Tax Expense | - | - | 665.17 | -282.01 | 188.09 | Upgrade
|
| Net Income | 1,562 | -16,358 | -3,526 | -3,136 | -1,059 | Upgrade
|
| Net Income to Common | 1,562 | -16,358 | -3,526 | -3,136 | -1,059 | Upgrade
|
| Shares Outstanding (Basic) | 19 | 20 | 20 | 20 | 20 | Upgrade
|
| Shares Outstanding (Diluted) | 19 | 20 | 20 | 20 | 20 | Upgrade
|
| Shares Change (YoY) | -3.33% | -0.26% | -0.03% | 0.55% | -0.16% | Upgrade
|
| EPS (Basic) | 81.00 | -820.00 | -176.28 | -156.75 | -53.25 | Upgrade
|
| EPS (Diluted) | 81.00 | -820.00 | -176.28 | -156.75 | -53.25 | Upgrade
|
| Free Cash Flow | -255.13 | -125.67 | -6,030 | -2,832 | -765.1 | Upgrade
|
| Free Cash Flow Per Share | -13.23 | -6.30 | -301.49 | -141.57 | -38.45 | Upgrade
|
| Gross Margin | 11.98% | -10.34% | -3.72% | -8.96% | -0.30% | Upgrade
|
| Operating Margin | 1.52% | -20.76% | -10.84% | -18.34% | -7.77% | Upgrade
|
| Profit Margin | 6.28% | -73.13% | -9.66% | -12.38% | -4.31% | Upgrade
|
| Free Cash Flow Margin | -1.03% | -0.56% | -16.52% | -11.18% | -3.12% | Upgrade
|
| EBITDA | 1,145 | -2,167 | -1,189 | -2,083 | 758.6 | Upgrade
|
| EBITDA Margin | 4.61% | -9.69% | -3.26% | -8.22% | 3.09% | Upgrade
|
| D&A For EBITDA | 768.54 | 2,476 | 2,769 | 2,565 | 2,668 | Upgrade
|
| EBIT | 376.91 | -4,643 | -3,958 | -4,648 | -1,909 | Upgrade
|
| EBIT Margin | 1.52% | -20.76% | -10.84% | -18.34% | -7.77% | Upgrade
|
| Advertising Expenses | - | 2 | - | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.